Atara Biotherapeutics, Inc. Uncategorized Contracts & Agreements

22 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment to Amended and Restated Commercialization Agreement between Atara Biotherapeutics, Inc. and Pierre Fabre Medicament (March 31, 2025)
Modification Agreements
Atara Biotherapeutics, Inc.
Biotechnology
2025
Description of Atara Biotherapeutics, Inc. Securities Registered Under Section 12 of the Exchange Act
Stock Agreements
Atara Biotherapeutics, Inc.
Biotechnology
2025
Amended and Restated Commercialization Agreement between Atara Biotherapeutics, Inc. and Pierre Fabre Medicament (October 31, 2023)
Collaboration Agreements
Atara Biotherapeutics, Inc.
Biotechnology
CA
2024
Amendment No. 1 to Commercialization Agreement between Atara Biotherapeutics, Inc. and Pierre Fabre Medicament
Modification Agreements
Atara Biotherapeutics, Inc.
Biotechnology
2022
Commercialization Agreement between Atara Biotherapeutics, Inc. and Pierre Fabre Medicament (October 2, 2021)
Distribution Agreements
Atara Biotherapeutics, Inc.
Biotechnology
DE
2022
Description of Atara Biotherapeutics, Inc. Securities Registered Under Section 12 of the Exchange Act
Stock Agreements
Atara Biotherapeutics, Inc.
Biotechnology
DE
2020
Atara Biotherapeutics, Inc. Nonstatutory Stock Option Grant Notice and Agreement (Inducement Award)
Stock Agreements
Atara Biotherapeutics, Inc.
Biotechnology
2017
Amendment No. 1 to Exclusive Option Agreement between Memorial Sloan Kettering Cancer Center and Atara Biotherapeutics, Inc.
Modification Agreements
Atara Biotherapeutics, Inc.
Biotechnology
NY
2015
Amendment No. 3 to Exclusive License Agreement between Amgen Inc. and Santa Maria Biotherapeutics, Inc.
License Agreements
Atara Biotherapeutics, Inc.
Biotechnology
2014
Amendment No. 2 to Exclusive License Agreement between Amgen Inc. and Santa Maria Biotherapeutics, Inc.
License Agreements
Atara Biotherapeutics, Inc.
Biotechnology
2014
Amendment No. 1 to Exclusive License Agreement between Amgen Inc. and Santa Maria Biotherapeutics, Inc.
License Agreements
Atara Biotherapeutics, Inc.
Biotechnology
2014
Amendment No. 2 to Exclusive License Agreement between Amgen Inc. and Pinta Biotherapeutics, Inc.
License Agreements
Atara Biotherapeutics, Inc.
Biotechnology
2014
Amendment No. 1 to Exclusive License Agreement between Amgen Inc. and Pinta Biotherapeutics, Inc.
License Agreements
Atara Biotherapeutics, Inc.
Biotechnology
2014
Amendment No. 2 to Exclusive License Agreement between Amgen Inc. and NINA Biotherapeutics, Inc.
License Agreements
Atara Biotherapeutics, Inc.
Biotechnology
2014
Amendment No. 1 to Exclusive License Agreement between Amgen Inc. and Nina Biotherapeutics, Inc.
License Agreements
Atara Biotherapeutics, Inc.
Biotechnology
2014
Atara Biotherapeutics, Inc. Amended and Restated 2018 Inducement Plan
Bonus & Incentive Agreements
Atara Biotherapeutics, Inc.
Biotechnology
DE
2020
Atara Biotherapeutics, Inc. 2018 Inducement Equity Incentive Plan
Bonus & Incentive Agreements
Atara Biotherapeutics, Inc.
Biotechnology
DE
2018
Office Lease Agreement between BPG Rock Westlake, LLC and Atara Biotherapeutics, Inc. for 4360 Park Terrace Drive, Westlake Village, CA
Lease Agreements
Atara Biotherapeutics, Inc.
Biotechnology
CA
2015
Atara, Inc. Employment Offer Letter to Heather D. Turner as Vice President and General Counsel
Employment Agreements
Atara Biotherapeutics, Inc.
Biotechnology
DE
2015
Exclusive Option Agreement between Memorial Sloan Kettering Cancer Center and Atara Biotherapeutics, Inc. for T-Cell Technology
Atara Biotherapeutics, Inc.
Biotechnology
NY
2015
Sublease Agreement between Accesia, Inc. and Atara Biotherapeutics, Inc. for 701 Gateway Blvd, South San Francisco
Lease Agreements
Atara Biotherapeutics, Inc.
Biotechnology
2014
Office Lease Agreement between Freeway Properties III and Atara Biotherapeutics, Inc.
Lease Agreements
Atara Biotherapeutics, Inc.
Biotechnology
CA
2014